Clinical Trial: Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor

U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07342127) titled 'Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor' on Jan. 06.

Brief Summary: Background : pregnancy and postpartum period are times of increased risk for deep vein thrombosis (DVT).

The incidence of venous thromboembolic disease (VTE) during pregnancy is estimated at 1-2 per 1,000, and this risk increases in the postpartum period, rising up to 80-fold. VTE is a multifactorial condition, and several studies have identified risk factors for DVT during this period. These factors may be related to the patient herself-such as age, overweight, smoking, a personal or f...